Back to speakers

Stanislas POL

Professor, MD, PhD

France

City: Paris

Institution: Hôpital Cochin

Contact: stanislas.pol@cch.aphp.fr


Biography of Stanislas POL

Dr. Stanislas Pol is Professor of Hepatology and Gastroenterology at Université Paris Sorbonne, Paris, France. He is the Head of the Liver department at Cochin Hospital, Paris, France. He attended an Hepatology and Gastroenterology residency, chief residency at the Necker-Enfants Malades University and molecular enzymology fellowship in Henri Mondor hospital. Dr Pol completed his MD thesis on hepatitis B virus occult infections in 1983 and his PhD thesis on the regulation of iso-enzymes of ALT in liver disease in 1992. Dr. Pol’s research interests involve: 1. Hepato-virology (diagnosis and therapy of viral hepatitis, especially in populations with immune deficiency; 2. the management of hepatocellular carcinoma and 3. reversal of cirrhosis.

He is the recipient of several research awards and fellowships.

He has published more than 300 primary and review articles in the field of liver diseases.  He has previously chaired the coordinated action 24 of the French Agency for AIDS and Viral Hepatitis (ANRS: therapeutic trials in viral hepatitis) and he is the clinical head of the French ANRS Hepather (HBV and HCV hepatitis) cohort.

He is a the head of a group in the research Inserm unit 1223 studying the immune pathology of Hepatitis C virus infection in Institut Pasteur, Paris, France.

He is the director of the Center of Translationnal Research of Institut Pasteur since 2015.

PHC's participations

12th PHC – 2019

Monday, January 14th 2019

Are there still difficulties to treat patients?

Tuesday, January 15th 2019

LUNCH WORKSHOPS AND SPECIAL LUNCH SYMPOSIUM - 1-Elimination of HCV. What we learned from ongoing national programs: Room 252B

11th PHC – 2018

Monday, January 15th 2018

Special populations -

Luncheon workshops - (chairman)

10th PHC – 2017

Monday, January 30th 2017

LUNCH WORKSHOPS - 3-DAAs treatment of patient with HIV-HCV co-infection (chairman) -

9th PHC – 2016

Monday, January 11th 2016

Who to treat? (chairman)

Lunch Workshops - Room 241 (chairman)

Patients with chronic Kidney diseases -

8th PHC – 2015

Monday, January 12th 2015

How to optimize current therapy of G1 patients (chairman)

7th PHC – 2014

Monday, January 13th 2014

Genotype 3 -

6th PHC – 2013

Tuesday, January 15th 2013

Immuno-suppressed patients -

5th PHC – 2012

Tuesday, January 31st 2012

Do IL28B or not do IL28B ? (chairman) -

4th PHC – 2011

Tuesday, January 18th 2011

HIV co-infection: does it make a difference? -

3rd PHC – 2009

Monday, January 19th 2009

Luncheons - Room 5 (chairman)

Tuesday, January 20th 2009

HBeAg-positive chronic hepatitis B (chairman)

2nd PHC – 2007

Monday, January 22nd 2007

3rd session (chairman)

1st PHC – 2004

Friday, September 10th 2004

Treatment of Chronic Hepatitis C in Special Populations (chairman) -

DAY 1 – Friday, August 28

Friday, August 28th 2015

Workshop 4: Severe liver diseases in HIV patients (chairman)

Saturday, August 29th 2015

Hepatitis C: new challenges in the era of DAAs (chairman)

Jeunes Hépatologues Conférence

Saturday, July 01st 2017

HÉPATITES VIRALES (chairman)

Monday, January 14th 2019

Progress and Challenges in Eliminating HCV: Treatment

12th PHC – 2019

Monday, January 14th 2019

Are there still difficulties to treat patients? -

Tuesday, January 15th 2019

LUNCH WORKSHOPS AND SPECIAL LUNCH SYMPOSIUM - 1-Elimination of HCV. What we learned from ongoing national programs: Room 252B -

13th PHC – 2019

Monday, January 13th 2020

Micro elimination